Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly.See plans and pricing.See plans →
Medincell Appoints Edna Venneker, Md As Chief Medical Officer
PRIVATESep 01, 2026•3 days ago
Position
Chief Medical Officer
Company
MedinCell
Edna Venneker, MD
MontpellierBiotechnologyHealth CareScience And Engineering
Description
Medincell has announced the appointment of Edna Venneker, MD, as Chief Medical Officer. Venneker brings extensive international experience in drug development to the role.
Company Information
Company
MedinCell
Location
Montpellier, Occitania, France
About
MedinCell is a clinical stage pharmaceutical company that develops a portfolio of long-acting injectable products in various therapeutic areas by combining its proprietary BEPO® technology with active ingredients already known and marketed. Through the controlled and extended release of the active pharmaceutical ingredient, MedinCell makes medical treatments more efficient, particularly thanks to improved compliance, i.e. compliance with medical prescriptions, and to a significant reduction in the quantity of medication required as part of a one-off or chronic treatment. The BEPO® technology makes it possible to control and guarantee the regular delivery of a drug at the optimal therapeutic dose for several days, weeks or months starting from the subcutaneous or local injection of a simple deposit of a few millimeters, fully bioresorbable. Based in Montpellier, MedinCell currently employs more than 140 people representing over 25 different nationalities.
Don't miss MedinCell's next move
Get an email the moment MedinCell changes its leadership, hires an exec, or expands, usually minutes after it happens.
MontpellierBiotechnologyHealth CareScience And Engineering